Bonell Patiño-Escobar

About Bonell Patiño-Escobar

Bonell Patiño-Escobar, With an exceptional h-index of 7 and a recent h-index of 7 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Multiple Myeloma, Acute leukemias, lymphoma.

His recent articles reflect a diverse array of research interests and contributions to the field:

CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

Discovery and Development of CD70 As a Cellular Therapy Target in High Risk Multiple Myeloma

Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target

P985: CLL-1 IS AN ADOPTIVE IMMUNOTHERAPY TARGET IN JUVENILE MYELOMONOCYTIC LEUKEMIA

Overcoming proteasome inhibitor resistance in the immunotherapy era

Multidisciplinary diagnosis and treatment of mantle cell lymphoma Expert consensus• Asociación Colombiana de Hematología y Oncología (ACHO)

Diagnóstico y tratamiento multidisciplinario de linfoma de células del manto

Bonell Patiño-Escobar Information

University

Position

Post doctoral Fellowship - (UCSF)

Citations(all)

501

Citations(since 2020)

497

Cited By

161

hIndex(all)

7

hIndex(since 2020)

7

i10Index(all)

6

i10Index(since 2020)

6

Email

University Profile Page

Google Scholar

Bonell Patiño-Escobar Skills & Research Interests

Multiple Myeloma

Acute leukemias

lymphoma

Top articles of Bonell Patiño-Escobar

CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma

Clinical Cancer Research

2024/3/1

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

bioRxiv

2024

Discovery and Development of CD70 As a Cellular Therapy Target in High Risk Multiple Myeloma

Blood

2023/11/28

Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target

Nature Cancer

2023/11

P985: CLL-1 IS AN ADOPTIVE IMMUNOTHERAPY TARGET IN JUVENILE MYELOMONOCYTIC LEUKEMIA

HemaSphere

2023/8/1

Overcoming proteasome inhibitor resistance in the immunotherapy era

2023/6/19

Bonell Patiño-Escobar
Bonell Patiño-Escobar

H-Index: 3

Multidisciplinary diagnosis and treatment of mantle cell lymphoma Expert consensus• Asociación Colombiana de Hematología y Oncología (ACHO)

Acta Medica Colombiana

2023/6

Diagnóstico y tratamiento multidisciplinario de linfoma de células del manto

Acta Médica Colombiana

2023/1/24

Machine learning and Deep learning applications in CAR-T research and development.

2022/10/6

Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance

Cell Stress

2022/11

Bonell Patiño-Escobar
Bonell Patiño-Escobar

H-Index: 3

Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma

Cell chemical biology

2022/8/18

Section 2. Colombian consensus for prophylaxis, treatment and prevention of invasive aspergillosis in adult and pediatric patients

Infectio

2022/7/31

Bonell Patiño-Escobar
Bonell Patiño-Escobar

H-Index: 3

Section 4. Colombian consensus on the diagnosis and treatment of chronic, saprophytic and/or allergic syndromes associated with Aspergillus spp. in adult and pediatric patients

Infectio

2022/7/31

Bonell Patiño-Escobar
Bonell Patiño-Escobar

H-Index: 3

Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients

Infectio

2022/7/31

Bonell Patiño-Escobar
Bonell Patiño-Escobar

H-Index: 3

Section 1. Colombian consensus on the diagnosis and follow-up of invasive aspergillosis and Aspergillus disease in adult and pediatric patients

Infectio

2022/7/30

Bonell Patiño-Escobar
Bonell Patiño-Escobar

H-Index: 3

The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance

Nature communications

2022/7/15

Consenso colombiano para la prevención, diagnóstico y manejo de condiciones trombóticas en pacientes adultos con COVID-19: aplicando el Marco de la Evidencia a la Decisión (EtD …

Acta Medica Colombiana

2021/3

Colombian consensus for the prevention, diagnosis and treatment of thrombotic conditions in adult patients with COVID-19: applying GRADE Evidence to Decision (EtD) frameworks

Acta Medica Colombiana

2021/6/16

Liliana Correa-Pérez
Liliana Correa-Pérez

H-Index: 1

Bonell Patiño-Escobar
Bonell Patiño-Escobar

H-Index: 3

P-103: Profiling the myeloma cell surface proteome reveals CCR10 as a potential immunotherapeutic target

Clinical Lymphoma Myeloma and Leukemia

2021/10/1

FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma

Blood Advances

2021/8/10

See List of Professors in Bonell Patiño-Escobar University(University of California, San Francisco)